These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26124505)

  • 1. High rates of false positives are likely in diabetes screening programmes in India.
    Bagcchi S
    BMJ; 2015 Jun; 350():h3535. PubMed ID: 26124505
    [No Abstract]   [Full Text] [Related]  

  • 2. The health system and population health implications of large-scale diabetes screening in India: a microsimulation model of alternative approaches.
    Basu S; Millett C; Vijan S; Hayward RA; Kinra S; Ahuja R; Yudkin JS
    PLoS Med; 2015 May; 12(5):e1001827; discussion e1001827. PubMed ID: 25992895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are people at high risk for diabetes visiting health facility for confirmation of diagnosis? A population-based study from rural India.
    Srinivasapura Venkateshmurthy N; Soundappan K; Gummidi B; Bhaskara Rao M; Tandon N; Reddy KS; Prabhakaran D; Mohan S
    Glob Health Action; 2018; 11(1):1416744. PubMed ID: 29334333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting an earlier diagnosis of diabetes starts with better screening.
    Petersen T
    Am J Manag Care; 2014 Jan; 20(1 Spec No.):E13. PubMed ID: 25928940
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of varying the screening interval on false positives and duration of undiagnosed disease in a screening programme for type 2 diabetes.
    Park PJ; Griffin SJ; Duffy SW; Wareham NJ
    J Med Screen; 2000; 7(2):91-6. PubMed ID: 11002449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for diabetes campaign].
    Maj C; Lemaire C
    Soins; 2002 Nov; (670):17-8. PubMed ID: 12465369
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for diabetes in general practice. Workload studies as well as clinical trials should be considered when drawing up guidelines.
    Bates M; Carmody P; Haba S; Smith S; Bradley C
    BMJ; 2002 Feb; 324(7334):426. PubMed ID: 11855396
    [No Abstract]   [Full Text] [Related]  

  • 8. Reasons to exercise caution when considering a screening program for type 2 diabetes mellitus.
    Lawler FH
    Mayo Clin Proc; 2009; 84(1):34-6. PubMed ID: 19121252
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for diabetes in general practice. Opportunistic screening for diabetes in general practice is better than nothing.
    Hagstrom B; Mattsson B
    BMJ; 2002 Feb; 324(7334):425-6. PubMed ID: 11850383
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for type 2 diabetes in the Iranian national programme: a preliminary report.
    Azizi F; Guoya MM; Vazirian P; Dolatshati P; Habbibian S
    East Mediterr Health J; 2003; 9(5-6):1122-7. PubMed ID: 16450546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating to target: implementing an effective diabetes care paradigm for managed care.
    Berger JE; Ahmann AJ; Balfour DC; Owens GS; Beltran R; Bush MA; Culpepper L; Owens GS; Ringel M; Welty FK
    Am J Manag Care; 2010 Mar; 16 Suppl Treating():S4-35. PubMed ID: 20297878
    [No Abstract]   [Full Text] [Related]  

  • 12. Early screening for diabetes mellitus: has it been overstated?
    Boucher FG
    Can Fam Physician; 2004 Nov; 50():1503-4. PubMed ID: 15597968
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for diabetes, impaired glucose tolerance, and cardiovascular risk in primary care: a Northland, New Zealand pilot study.
    White B; Chamberlain N
    N Z Med J; 2009 May; 122(1295):28-37. PubMed ID: 19648984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening and intervention. A strategy in type 2 diabetes?].
    Jørgensen T; Glümer C; Borch-Johnsen K
    Ugeskr Laeger; 2002 Apr; 164(16):2135-9. PubMed ID: 11989055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for diabetic retinopathy in children and young people in the UK: potential gaps in ascertainment of those at risk.
    Ibanez-Bruron MC; Solebo AL; Cumberland PM; Rahi JS;
    Diabet Med; 2017 Jul; 34(7):1012-1013. PubMed ID: 28375545
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective.
    Spijkerman A; Griffin S; Dekker J; Nijpels G; Wareham NJ
    J Med Screen; 2002; 9(4):187-90. PubMed ID: 12518011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should diabetes retinal screening intervals change?
    Leese GP
    Diabet Med; 2013 Jan; 30(1):43-5. PubMed ID: 22823411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus screening has no effect on mortality.
    Yoon U
    Evid Based Med; 2015 Aug; 20(4):136. PubMed ID: 26116158
    [No Abstract]   [Full Text] [Related]  

  • 19. [Type 2 Diabetes mellitus-screening and prevention: Update 2016].
    Stadler M; Fröhlich-Reiterer E; Prager R
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S41-4. PubMed ID: 27052220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Type 2 Diabetes Mellitus.
    Selph S; Blazina I; Chou R
    Ann Intern Med; 2015 Nov; 163(9):726-7. PubMed ID: 26524579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.